Gut Microbiota Influences Postoperative Cognitive Dysfunction through Indole-3-Propionic Acid
肠道微生物群通过吲哚-3-丙酸影响术后认知功能
基本信息
- 批准号:10238041
- 负责人:
- 金额:$ 40.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAmpicillinAnesthesia proceduresApplications GrantsBiological AssayClinicalClinical TreatmentCommunitiesComplexDevelopmentDietGenerationsGeneticGrantHippocampus (Brain)ImmunologicsImpairmentIndolesInflammatoryIsofluraneLeadLearningLinkMemoryMetagenomicsMitochondriaMusNADHNeuraxisOperative Surgical ProceduresOralOral AdministrationOutcomePathogenesisPatientsPostoperative PeriodProductionPropionic AcidsProteinsPublic HealthReactive Oxygen SpeciesResearchRisk FactorsRoleStructureSulfateTranslatingbasedietaryfemoral arterygut dysbiosisgut microbiotaindoxylmetabolomicsmicrobiota metabolitesmortalitynervous system disorderneurobehavioralnovelnovel therapeutic interventionoxidationpost-operative cognitive dysfunctionpreventprograms
项目摘要
In up to 26% surgical patients, subtle yet persistent deficits in learning and memory occur postoperatively,
referred to as postoperative cognitive dysfunction (POCD). POCD has become a serious public health concern
as it is associated with worse clinical outcomes including increased mortality. The pathogenesis underlying
POCD remains unclear. Both modifiable and non-modifiable factors may contribute to POCD. To date, studies
on POCD have primarily focused on direct influences of surgery and anesthesia on the central nervous system,
which have identified age and genetics as major risk factors in POCD. Unfortunately, these are non-modifiable
factors and difficult to be translated into clinical treatment. As such, there is an urgent need to identify
modifiable factors underlying POCD. Among many modifiable factors, dietary influences and gut microbiota
have been implicated in many neurological diseases with inflammatory features. Whether gut microbiota
influences POCD has yet to be examined. In our preliminary studies, we observed a previously unrecognized
role for gut microbiota in the development of POCD in mice post femoral artery exposure under isoflurane
anesthesia. Specifically, we found: 1) mice with normal gut microbiota did not develop POCD while mice with
gut dysbiosis developed POCD; 2) oral ampicillin treatment led to a status of gut dysbiosis, characterized by
gut microbiota community structure changes and a dramatic decrease of indoles, particularly indoxyl-3-sulfate
(IS) and indole-3-propionic acid (IPA); 3) oral administration of IPA, but not IS, deterred the POCD
development; 4) mice with POCD displayed increased oxidation and impaired mitochondria function in the
hippocampus, suggested by an enhanced production of reactive oxygen species (ROS), decreased production
of NADH, and decreased protein levels of NDUFS4 (a critical mitochondria complex I component), when
compared with mice without POCD; and 5) oral administration of IPA decreased ROS generation, increased
NADH production and NDUFS4 protein levels in the hippocampus of ampicillin-treated mice. Based on these
preliminary findings, we hypothesize that gut microbiota has a key influence on the development of POCD
through IPA. In the research program proposed in this grant, we will examine the hypothesis by addressing
three key questions: 1) Does the observed effect of gut dysbiosis on POCD represent an epiphenomenon or a
‘permissive’ effect? 2) What are the mechanisms underlying the IPA’s protective role in POCD? and 3) Can we
develop a strategy based on gut microbiota and metabolites to prevent and treat POCD? This grant is built on
our novel preliminary findings and our established research platform that combines cutting-edge
metagenomics and metabolomics with immunological and neurobehavioral assays. Successful execution of
this proposal will establish a novel conceptual framework linking modifiable factors such as diet and gut
microbiota with POCD, and lead to new therapeutic strategies.
在高达26%的手术患者中,术后会出现微小但持续的学习和记忆障碍,
称为术后认知功能障碍(POCD)。POCD已成为一个严重的公共卫生问题
因为它与更差的临床结果相关,包括增加死亡率。潜在的发病机制
POCD仍不清楚。可修改因素和不可修改因素都可能导致POCD。到目前为止,研究
关于POCD的研究主要集中在手术和麻醉对中枢神经系统的直接影响,
他们认为年龄和遗传因素是POCD的主要危险因素。不幸的是,这些是不可修改的
因素多,难以转化为临床治疗。因此,迫切需要确定
POCD背后的可修改因素。在许多可改变的因素中,饮食影响和肠道微生物区系
与许多具有炎症特征的神经系统疾病有牵连。肠道微生物区系是否
POCD的影响还有待研究。在我们的初步研究中,我们观察到了一种以前未被认识到的
肠道微生物区系在小鼠股动脉异氟醚暴露后POCD发生中的作用
麻醉。具体地说,我们发现:1)肠道微生物区系正常的小鼠没有发生POCD,而肠道微生物区系正常的小鼠
肠道菌群失调发展为POCD;2)口服氨苄西林治疗导致肠道菌群失调状态,其特征为
肠道微生物群落结构的变化和吲哚的急剧减少,特别是吲哚-3-硫酸酯
(3)口服吲哚-3-丙酸(IPA),而不是IS,可阻止POCD
4)POCD小鼠表现出氧化增加和线粒体功能受损。
海马区,由于增加了活性氧物种(ROS)的产生,减少了产生
NADH,并降低NDUFS4(一种关键的线粒体复合体I组分)的蛋白水平
5)口服异丙肾上腺素能减少ROS的生成,增加ROS的生成
氨苄西林处理的小鼠海马区NADH产生和NDUFS4蛋白水平。基于这些
初步发现,我们假设肠道微生物区系对POCD的发展有关键影响。
通过IPA。在这项拨款中提出的研究计划中,我们将通过以下方式检验这一假说
三个关键问题:1)观察到的肠道生物失调对POCD的影响是一种附生现象还是一种
“放任”效应?2)IPA在POCD中起保护作用的机制是什么?以及3)我们可以
开发基于肠道微生物区系和代谢物的策略来预防和治疗POCD?这笔赠款是建立在
我们的新的初步发现和我们建立的结合了尖端技术的研究平台
元基因组学和代谢组学与免疫学和神经行为分析。成功执行
这项提议将建立一个新的概念框架,将饮食和肠道等可改变的因素联系起来
微生物群与POCD,并导致新的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shiqian Shen其他文献
Shiqian Shen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shiqian Shen', 18)}}的其他基金
Gut Microbiota Underlies the Heterogeneity of Aging Brain's Susceptibility to Postoperative Delirium
肠道微生物群是衰老大脑对术后谵妄易感性异质性的基础
- 批准号:
10297433 - 财政年份:2021
- 资助金额:
$ 40.02万 - 项目类别:
Microbiome Dysbiosis and Postoperative Delirium Pathogenesis
微生物群失调与术后谵妄发病机制
- 批准号:
10055132 - 财政年份:2020
- 资助金额:
$ 40.02万 - 项目类别:
Development and Validation of a Clinically Relevant Animal Pain Model
临床相关动物疼痛模型的开发和验证
- 批准号:
10460795 - 财政年份:2020
- 资助金额:
$ 40.02万 - 项目类别:
Aging Promotes Pain Chronification through Changes in PGC-1alpha Expression and Interneuron Dysfunction
衰老通过 PGC-1α 表达的变化和中间神经元功能障碍促进疼痛慢性化
- 批准号:
10250503 - 财政年份:2020
- 资助金额:
$ 40.02万 - 项目类别:
Aging Promotes Pain Chronification through Changes in PGC-1alpha Expression and Interneuron Dysfunction
衰老通过 PGC-1α 表达的变化和中间神经元功能障碍促进疼痛慢性化
- 批准号:
10026358 - 财政年份:2020
- 资助金额:
$ 40.02万 - 项目类别:
Gut Microbiota Influences Postoperative Cognitive Dysfunction through Indole-3-Propionic Acid
肠道微生物群通过吲哚-3-丙酸影响术后认知功能
- 批准号:
9759966 - 财政年份:2018
- 资助金额:
$ 40.02万 - 项目类别:
Gut Microbiota Influences Postoperative Cognitive Dysfunction through Indole-3-Propionic Acid
肠道微生物群通过吲哚-3-丙酸影响术后认知功能
- 批准号:
10475064 - 财政年份:2018
- 资助金额:
$ 40.02万 - 项目类别:
Administrative Supplement: Gut Microbiota Influences Postoperative Cognitive Dysfunction through Indole-3-Propionic Acid
行政补充:肠道微生物群通过吲哚-3-丙酸影响术后认知功能障碍
- 批准号:
10388931 - 财政年份:2018
- 资助金额:
$ 40.02万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 40.02万 - 项目类别:
Directed Grant